Citadel Advisors’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,709
| Closed | -$35.3K | – | 7051 |
|
|
2024
Q2 | $35.3K | Buy |
14,709
+2,633
| +22% | +$6.32K | ﹤0.01% | 5273 |
|
|
2024
Q1 | $59.4K | Sell |
12,076
-48,294
| -80% | -$238K | ﹤0.01% | 5275 |
|
|
2023
Q4 | $252K | Buy |
60,370
+38,810
| +180% | +$162K | ﹤0.01% | 4396 |
|
|
2023
Q3 | $319K | Buy |
21,560
+2
| +0% | +$30 | ﹤0.01% | 4206 |
|
|
2023
Q2 | $629K | Sell |
21,558
-46,090
| -68% | -$1.35M | ﹤0.01% | 3423 |
|
|
2023
Q1 | $1.57M | Buy |
67,648
+185
| +0.3% | +$4.29K | ﹤0.01% | 2746 |
|
|
2022
Q4 | $971K | Buy |
67,463
+835
| +1% | +$12K | ﹤0.01% | 3228 |
|
|
2022
Q3 | $1.6M | Hold |
66,628
| – | – | ﹤0.01% | 2960 |
|
|
2022
Q2 | $1.33M | Sell |
66,628
-895
| -1% | -$17.9K | ﹤0.01% | 3113 |
|
|
2022
Q1 | $2.39M | Sell |
67,523
-425
| -0.6% | -$15K | ﹤0.01% | 2828 |
|
|
2021
Q4 | $3.04M | Sell |
67,948
-777
| -1% | -$34.8K | ﹤0.01% | 2599 |
|
|
2021
Q3 | $4.89M | Sell |
68,725
-3,732
| -5% | -$266K | ﹤0.01% | 2062 |
|
|
2021
Q2 | $9.57M | Buy |
72,457
+56,144
| +344% | +$7.41M | ﹤0.01% | 1485 |
|
|
2021
Q1 | $2.19M | Buy |
16,313
+15,414
| +1,715% | +$2.07M | ﹤0.01% | 3060 |
|
|
2020
Q4 | $66K | Buy |
+899
| New | +$66K | ﹤0.01% | 4801 |
|